Collplant Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.08.24	CollPlant Biotechnologies Posts Loss In Q2 - Quick Facts (RTTNews)
04.04.24	CollPlant Biotechnologies FY23 Net Loss Narrows (RTTNews)
29.03.23	Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update (PR Newswire)
22.12.20	NantKwest Stock Goes North, QURE's HOPE-B Trial On Hold, EU Greenlights First COVID-19 Vaccine (RTTNews)
01.12.20	CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update (PR Newswire)
10.11.20	CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients (PR Newswire)
26.10.20	CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine (PR Newswire)
16.10.20	SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch (RTTNews)
15.10.20	FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade (RTTNews)
21.09.20	CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant (PR Newswire)
16.09.20	CollPlant Biotechnologies Presents on the Use of Novel, Plant-Derived, Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020 (PR Newswire)
14.09.20	CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS) (PR Newswire)
31.08.20	CollPlant Biotechnologies to Present at Science of Aging Virtual Symposium 2020 During Healthy Aging Month (PR Newswire)
28.08.20	CollPlant Biotechnologies Reports Second Quarter (Q2) 2020 Financial Results (PR Newswire)
27.05.20	CollPlant Biotechnologies Reports First Quarter (Q1) 2020 Financial Results (PR Newswire)
05.05.20	Collplant to Host Webinar Highlighting its Plant-based, Human Recombinant Collagen (rhCollagen) Platform for the Future of Aesthetic and Regenerative Medicine (PR Newswire)
01.04.20	CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019 (PR Newswire)
14.02.20	CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement (PR Newswire)
10.02.20	CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors (PR Newswire)
04.02.20	CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments (PR Newswire)
13.01.20	3D Systems and CollPlant Biotechnologies Join Forces to Accelerate Breakthroughs in Regenerative Medicine (PR Newswire)
06.01.20	CollPlant Partners in the Advanced Regenerative Manufacturing Institute (PR Newswire)
19.12.19	CollPlant Publishes Letter to Shareholders (PR Newswire)
29.11.19	CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update (PR Newswire)
22.10.19	CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee (PR Newswire)
16.10.19	CollPlant to Present at Dawson James Small Cap Growth Conference on October 29, 2019 in Florida (PR Newswire)
26.09.19	CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update (PR Newswire)
09.09.19	CollPlant Biotechnologies Closes on $5.5 Million Financing (PR Newswire)
05.09.19	CollPlant Biotechnologies to Present at the 21st Annual Rodman & Renshaw Global Investment Conference (PR Newswire)
03.09.19	CollPlant Biotechnologies Raising $5.5 Million (PR Newswire)
05.08.19	CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue (PR Newswire)
20.06.19	CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business (PR Newswire)
04.06.19	Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference (PR Newswire)
23.04.19	CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City (PR Newswire)
01.04.19	CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update (PR Newswire)
11.03.19	Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks (PR Newswire)
10.12.18	Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix™ STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow (PR Newswire)
12.11.18	CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants (PR Newswire)
07.11.18	CollPlant to Ring Nasdaq Opening Bell on November 8, 2018 (PR Newswire)
28.08.18	CollPlant Holdings to Present at the 20th Annual Rodman & Renshaw Global Investment Conference (PR Newswire)
26.06.18	CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs (PR Newswire)
19.06.18	CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board (PR Newswire)
24.05.18	CollPlant Reports First Quarter 2018 Financial Results and Provides Business Update (PR Newswire)
12.04.18	CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer (PR Newswire)
28.11.17	CollPlant Expands European Sales Network: The Company Has Signed a Distribution Agreement in Greece and Cyprus for Vergenix®FG for Treatment of Acute and Chronic Wounds and Surgical Cuts (PR Newswire)
13.11.17	Vote of Confidence in CollPlant: Completion of Agreement for Immediate Investment of USD 1.1 Million from Ami Sagi, one of the Company's Largest Shareholders (PR Newswire)
11.09.17	CollPlant Signs Definitive Agreement for $5 Million Private Placement with US Investor (PR Newswire)
05.09.17	CollPlant in Advanced Negotiations for US Private Placement of USD 5.0 million; Agreement Includes Plan for NASDAQ Uplisting (PR Newswire)
12.06.17	CollPlant Files Patent for 3D Bio-Printing of Organs and Tissues (PR Newswire)
31.05.17	CollPlant Provides Operational Update for Q1 2017 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Collplant Holdings Ltd.

Aktien Top/Flop

Meistgelesene Nachrichten